Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...

The failure in adjuvant melanoma could cause BMS and Opdualag to miss out on a market opportunity that is nearly twice as large as its current approved indication, according to analysts.

The alcohol industry is undergoing a significant transformation with the rise of cannabis-infused and alternative beverages. Yet, bringing these products to market is anything but simple.

The strides we've made in this field inspire hope for a future where hearing loss is not a barrier but a challenge we can ...

For the quarter, the fund's Retail Class shares gained 8.15%, topping the 6.35% advance of the benchmark, the NASDAQ ...

Jefferies has set a new price target of 370p for M&S, down from its previous target of 410p. This adjustment reflects a more cautious approach as analysts weigh the balance between a strengthening UK ...

Despite market challenges and the ongoing need for growth capital to support new sales, the Boston Solar team has remained resilient, successfully driving business forward. Furthermore, operational ...

it does come with challenges. The increase in consumer credit and unsecured lending signals a potential risk to financial stability. With so many young investors entering the market, it’s ...

Although Tesla’s fourth-quarter deliveries in 2024 aligned with market consensus, they fell short of the company’s own growth projections. The company faces challenges such as the IRA roll ...

These challenges have all fed into ... This can create new revenue streams and expand market reach for altnets, helping them monetize their networks in areas where they are struggling for subscribers.

Trading activity ramped up notably in Q4 versus Q3 2024 as well, reflecting consistent upward momentum within OTC Markets Group's offerings driven by robust cross-trading opportunities that ...